Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Receptor agonists as perspective neuroprotective agents].

V I Kulinskiĭ

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |October 31, 2000
    PubMed
    Summary

    Selective receptor agonists offer significant neuroprotection against complete cerebral ischemia (CI) by directly protecting brain tissue. These promising neuroprotective receptor drugs may extend therapeutic windows for treating CI.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Influence of alpha-lipoic acid on liver glutathione system of healthy and Ehrlich ascites carcinoma transplanted mice].

    Biomeditsinskaia khimiia·2011
    Same author

    [Nuclear glutathione and its functions].

    Biomeditsinskaia khimiia·2011
    Same author

    [Glutathione system. II. Other enzymes, thiol-disulphide metabolism, inflammation and immunity, functions].

    Biomeditsinskaia khimiia·2009
    Same author

    [Importance of selective A1 agonists for the protection of brain and heart against injuring factors].

    Eksperimental'naia i klinicheskaia farmakologiia·2009
    Same author

    [Glutathione system. I. Synthesis, transport, glutathione transferases, glutathione peroxidases].

    Biomeditsinskaia khimiia·2009
    Same author

    [The erythrocyte and plasma glutathione system under peptic ulcer].

    Biomeditsinskaia khimiia·2008

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Ischemic Stroke Research

    Context:

    • Complete cerebral ischemia (CI) poses a significant threat to brain tissue.
    • Existing treatments for CI have limitations in protecting core ischemic areas.
    • Understanding neuroprotective mechanisms is crucial for developing effective therapies.

    Purpose:

    • To investigate the neuroprotective effects (NPE) of selective receptor agonists in models of complete cerebral ischemia (CI).
    • To determine if neuroprotection is mediated by improved cerebral blood flow or direct brain protection.
    • To explore the potential of receptor neuroprotectors (RNP) as therapeutic agents for CI.

    Summary:

    • Selective agonists for adenosine A1, GABAa, GABAb, and alpha 2-receptors demonstrated high neuroprotective effects in CI models.
    • Neuroprotection was specific, inhibited by antagonists, and not observed with alpha 1- or beta-receptor agonists.
    • These receptor agonists protect brain tissue directly, not by improving cerebral blood flow, employing a tolerance strategy involving hypothermia.

    Impact:

    • Receptor neuroprotectors (RNP) protect both the penumbra and core ischemic zones, unlike most drugs.
    • RNPs are effective in complete global CI, expanding treatment possibilities.
    • RNP-induced delay in irreversible lesions could broaden the therapeutic window for other CI drugs, showing their promise.

    Related Experiment Videos